These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 16765359

  • 1. Effects of nitric oxide synthase inhibition and L-arginine on renal haemodynamics in young patients at high cardiovascular risk.
    Schlaich MP, Oehmer S, Schneider MP, Delles C, Schmidt BM, Schmieder RE.
    Atherosclerosis; 2007 May; 192(1):155-60. PubMed ID: 16765359
    [Abstract] [Full Text] [Related]

  • 2. Impaired basal NO activity in patients with glomerular disease and the influence of oxidative stress.
    Schäufele TG, Schlaich MP, Delles C, Klingbeil AU, Fleischmann EH, Schmieder RE.
    Kidney Int; 2006 Sep; 70(6):1177-81. PubMed ID: 16883318
    [Abstract] [Full Text] [Related]

  • 3. Increased response of renal perfusion to the antioxidant vitamin C in type 2 diabetes.
    Delles C, Schneider MP, Oehmer S, Fleischmann I, Fleischmann EF, Schmieder RE.
    Nephrol Dial Transplant; 2004 Oct; 19(10):2513-8. PubMed ID: 15266036
    [Abstract] [Full Text] [Related]

  • 4. Impact of the endothelial nitric oxide synthase gene G894T polymorphism on renal endothelial function in patients with type 2 diabetes.
    Ritt M, Ott C, Delles C, Schneider MP, Schmieder RE.
    Pharmacogenet Genomics; 2008 Aug; 18(8):699-707. PubMed ID: 18622262
    [Abstract] [Full Text] [Related]

  • 5. Gender is related to alterations of renal endothelial function in type 2 diabetes.
    Schneider MP, Ritt M, Raff U, Ott C, Schmieder RE.
    Nephrol Dial Transplant; 2009 Nov; 24(11):3354-9. PubMed ID: 19567476
    [Abstract] [Full Text] [Related]

  • 6. Vitamin C augments the renal response to L-arginine in smokers.
    Schneider MP, Klingbeil AU, Delles C, Schmidt BM, John S, Schmieder RE.
    Nephrol Dial Transplant; 2003 Aug; 18(8):1512-7. PubMed ID: 12897088
    [Abstract] [Full Text] [Related]

  • 7. Assessment of endothelial function of the renal vasculature in human subjects.
    Delles C, Jacobi J, Schlaich MP, John S, Schmieder RE.
    Am J Hypertens; 2002 Jan; 15(1 Pt 1):3-9. PubMed ID: 11824856
    [Abstract] [Full Text] [Related]

  • 8. Is l-arginine infusion an adequate tool to assess endothelium-dependent vasodilation of the human renal vasculature?
    Schlaich MP, Jacobi J, John S, Delles C, Fleischmann I, Schmieder RE.
    Clin Sci (Lond); 2000 Oct; 99(4):293-302. PubMed ID: 10995594
    [Abstract] [Full Text] [Related]

  • 9. Renal effects of NO-inhibition in patients with cirrhosis vs. healthy controls: a randomized placebo-controlled crossover study.
    Bech JN, Aagaard NK, Pedersen RS, Sorensen TB, Vilstrup H, Pedersen EB.
    Liver Int; 2014 Feb; 34(2):211-9. PubMed ID: 23809512
    [Abstract] [Full Text] [Related]

  • 10. Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition.
    Millar CG, Thiemermann C.
    Br J Pharmacol; 1997 Aug; 121(8):1824-30. PubMed ID: 9283724
    [Abstract] [Full Text] [Related]

  • 11. Rosuvastatin improves basal nitric oxide activity of the renal vasculature in patients with hypercholesterolemia.
    Ott C, Schlaich MP, Schmidt BM, Titze SI, Schäufele T, Schmieder RE.
    Atherosclerosis; 2008 Feb; 196(2):704-11. PubMed ID: 17298834
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic-pharmacodynamic profile of systemic nitric oxide-synthase inhibition with L-NMMA in humans.
    Mayer BX, Mensik C, Krishnaswami S, Derendorf H, Eichler HG, Schmetterer L, Wolzt M.
    Br J Clin Pharmacol; 1999 May; 47(5):539-44. PubMed ID: 10336578
    [Abstract] [Full Text] [Related]

  • 13. Characterization of local vascular effects of the nitric oxide inhibitor NG-monomethyl-L-arginine on dorsal hand veins.
    Schindler C, Leuschner S, Schwanebeck U, Kirch W.
    J Clin Pharmacol; 2012 Jun; 52(6):859-69. PubMed ID: 21566204
    [Abstract] [Full Text] [Related]

  • 14. Effect of nitric oxide synthase inhibition on renal hemodynamics in humans: reversal by L-arginine.
    Wolzt M, Schmetterer L, Ferber W, Artner E, Mensik C, Eichler HG, Krejcy K.
    Am J Physiol; 1997 Feb; 272(2 Pt 2):F178-82. PubMed ID: 9124393
    [Abstract] [Full Text] [Related]

  • 15. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients.
    John S, Schneider MP, Delles C, Jacobi J, Schmieder RE.
    Am Heart J; 2005 Mar; 149(3):473. PubMed ID: 15864218
    [Abstract] [Full Text] [Related]

  • 16. L-arginine-induced growth hormone secretion is not influenced by co-infusion of the nitric oxide synthase inhibitor N-monomethyl-L-arginine in healthy men.
    Fisker S, Nielsen S, Ebdrup L, Bech JN, Christiansen JS, Pedersen EB, Jørgensen JO.
    Growth Horm IGF Res; 1999 Feb; 9(1):69-73. PubMed ID: 10207510
    [Abstract] [Full Text] [Related]

  • 17. Basal nitric oxide synthase activity is a major determinant of glomerular haemodynamics in humans.
    Schlaich MP, Schmitt D, Ott C, Schmidt BM, Schmieder RE.
    J Hypertens; 2008 Jan; 26(1):110-6. PubMed ID: 18090547
    [Abstract] [Full Text] [Related]

  • 18. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia.
    Stroes E, Kastelein J, Cosentino F, Erkelens W, Wever R, Koomans H, Lüscher T, Rabelink T.
    J Clin Invest; 1997 Jan 01; 99(1):41-6. PubMed ID: 9011574
    [Abstract] [Full Text] [Related]

  • 19. Neuronal nitric oxide synthase regulates basal microvascular tone in humans in vivo.
    Seddon MD, Chowienczyk PJ, Brett SE, Casadei B, Shah AM.
    Circulation; 2008 Apr 15; 117(15):1991-6. PubMed ID: 18391107
    [Abstract] [Full Text] [Related]

  • 20. Effects of a nitric oxide synthase inhibitor on pressor response to angiotensin II in conscious rats.
    Maeda T, Yoshimura T, Ohshige A, Koyama H, Ito M, Okamura H.
    Artery; 1998 Apr 15; 23(1):1-9. PubMed ID: 10846613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.